Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
about
Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloofEgg beater as centrifuge: isolating human blood plasma from whole blood in resource-poor settingsAMP-activated protein kinase, stress responses and cardiovascular diseasesIn vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular diseaseHow hyperglycemia promotes atherosclerosis: molecular mechanisms.Usefulness of electronic databases for the detection of unrecognized diabetic patientsIs type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stressCardio-protective effects of carnitine in streptozotocin-induced diabetic rats.Differing myocardial response to a single session of hemodialysis in end-stage renal disease with and without type 2 diabetes mellitus and coronary artery disease.Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapyCardiovascular Effects of Glucagon-Like Peptide-1 Receptor AgonistsFishing for Nature's Hits: Establishment of the Zebrafish as a Model for Screening Antidiabetic Natural ProductsPhytochemical Compounds and Protection from Cardiovascular Diseases: A State of the ArtMaternal obesity during pregnancy and cardiovascular development and disease in the offspringType-2 diabetes: Current understanding and future perspectivesCardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonistsClinical review: Screening for coronary artery disease in type 2 diabetes.Coronary atherosclerosis is already ongoing in pre-diabetic status: Insight from intravascular imaging modalitiesMR imaging of the coronary vasculature: imaging the lumen, wall, and beyondScreening for asymptomatic coronary artery disease in patients with diabetes mellitus: A systematic review and meta-analysis of randomized trialsUpdate on RAAS Modulation for the Treatment of Diabetic Cardiovascular DiseaseDiagnosis and management of diabetes and the relationship of dglucose to kidney functionCardiovascular disease in type 2 diabetes: challenge for treatment and preventionCardiovascular prevention before admission reduces mortality following acute myocardial infarction in patients with diabetesReducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education ProgramA hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular diseaseJob strain as a risk factor for type 2 diabetes: a pooled analysis of 124,808 men and womenAn ethanolic extract of Lindera obtusiloba stems, YJP-14, improves endothelial dysfunction, metabolic parameters and physical performance in diabetic db/db miceUrsolic acid increases glucose uptake through the PI3K signaling pathway in adipocytesDevelopment of an OP9 derived cell line as a robust model to rapidly study adipocyte differentiation.MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism.Human risk of diseases associated with red meat intake: Analysis of current theories and proposed role for metabolic incorporation of a non-human sialic acidThe current role of thiazolidinediones in diabetes management.Therapy insight: heart disease and the insulin-resistant patient.Obesity: from the agricultural revolution to the contemporary pediatric epidemic.Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trialAn exploratory spatial analysis to assess the relationship between deprivation, noise and infant mortality: an ecological study.Relationship between Food-frequency and Glycated Hemoglobin in Korean Diabetics: Using Data from the 4th Korea National Health and Nutrition Examination Survey.Type 2 diabetes alters bone and marrow blood flow and vascular control mechanisms in the ZDF rat.Susceptible gene of stasis-stagnation constitution from genome-wide association study related to cardiovascular disturbance and possible regulated traditional Chinese medicine.
P2860
Q21246039-C57BEA9C-6083-4396-9EA0-5E623E4CA834Q24289278-309ECA10-B06A-4389-9488-2E9785BFB909Q24610297-2267E567-1122-4175-926F-4E46E8FE7033Q24681371-9A227A55-4389-4140-9ADF-ABD305A05EDFQ24795988-437DB5D7-B7E0-4E60-A326-6F8362E58757Q24802056-AF43326D-4B8D-49CF-ACD6-71C9AB007EA1Q24805294-1E51089F-4F7B-474C-A875-8684732AEE23Q25256182-83C1A900-15EC-4EAF-8E9E-8F73DD076F4EQ25257664-936C24F8-4CA2-4865-819C-AC2EC8FB35D1Q26738281-BB659DC9-1E88-43A3-BD8C-C4D36DF8D37BQ26749495-C58C45AD-5125-49C4-A176-CA49CC0AC9AEQ26774936-F315E417-B2E0-47F7-A29A-99F9F6E3D1E4Q26778562-55A1C5A6-93E5-4628-B76F-98B436D0CF76Q26786041-A685C6E7-BD05-473C-A873-599BCD1F7ED1Q26801324-91A0C2B5-DB73-4638-A38E-BF03EB59BB09Q26823085-3EB40030-F3FE-42C0-888B-1D7439494142Q26860716-0539FF5A-6454-4183-97E9-B7AB8BF89452Q26866204-F10A28DE-68B7-41AF-A799-5523C1B55362Q26991944-55D1CECD-7064-4257-8626-DBBAA40CAF8DQ28067628-8233483A-FBA9-439B-A4E7-DD9A61751F71Q28077454-DF58D9EE-4BA3-4BB0-821F-A1F6C028433FQ28088437-66D3A622-0D7F-48B8-9472-C3172F51B972Q28181344-BD0B493B-6702-49F1-874B-F11DCB712D17Q28192788-A4F67437-33A2-45EB-AE13-1FCB6CA22F56Q28201111-E6F0446A-A92E-45CC-B5B1-FE125E5E8DDFQ28361892-605B5B0F-66C7-4859-B88D-A9BDE4911E9FQ28391142-443D9455-CF75-4F03-804D-67FB901EB41FQ28533586-A1057513-2787-4A10-9AD2-949CACF7CAEFQ28543943-DBC25896-A347-47D7-AF20-266A631B10D0Q28545038-9A44F916-B632-4BD3-A521-80DA9169EA8DQ29871002-EF211DED-101A-4051-86E7-B0DA33D6CF65Q30248988-567F0CB1-766A-4DD9-8D1D-8457D95C7C06Q30250347-A49BE3B6-0C2A-446C-8F78-1C25EFC8F068Q30351748-9673C0E9-9216-4761-8543-DB302AE4417CQ30412544-013C11FA-387F-4E83-B5E6-813EB514734FQ30435687-0D7AB355-F2DB-4E51-B7FF-0BA958726CCBQ30444632-46966C6E-FD48-4A87-BEF3-A649084D94EFQ30575613-8E9549E5-AD63-4577-87C5-852EE12486E0Q30633470-4B30F980-74DE-41FA-9AF1-AD4317EAEDBDQ30657668-D47C2195-5C45-446D-BF13-972ABEC1C13D
P2860
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Diabetes and cardiovascular di ...... he American Heart Association.
@ast
Diabetes and cardiovascular di ...... he American Heart Association.
@en
type
label
Diabetes and cardiovascular di ...... he American Heart Association.
@ast
Diabetes and cardiovascular di ...... he American Heart Association.
@en
prefLabel
Diabetes and cardiovascular di ...... he American Heart Association.
@ast
Diabetes and cardiovascular di ...... he American Heart Association.
@en
P2093
P1433
P1476
Diabetes and cardiovascular di ...... he American Heart Association.
@en
P2093
Benjamin IJ
Smith SC Jr
P304
P356
10.1161/01.CIR.100.10.1134
P407
P577
1999-09-01T00:00:00Z